Pasteurella multocida tracheobronchitis in a patient with CLL on rituximab.
Deming
Dustin
D
Silverman
Elizabeth
E
D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001991:Bronchitis / Q000139:chemically induced / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D010326:Pasteurella Infections / Q000139:chemically induced / Q000188:drug therapy* / Q000382:microbiology; D016979:Pasteurella multocida; D000069283:Rituximab; D014136:Tracheitis / Q000139:chemically induced / Q000188:drug therapy* / Q000382:microbiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage*
D000890:Anti-Infective Agents; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D015662:Trimethoprim, Sulfamethoxazole Drug Combination